PMV Pharmaceuticals, Inc
Symbol: PMVP (NASDAQ)
1.32
▼ (-17.56%) -0.281
Company Description:
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Key Stats
- Today's Open: $1.8
- Today's High: $3.034
- Today's Low: $1.195
- Today's Volume: 32.93M
- Yesterday Close: $1.6
- Yesterday High: $1.66
- Yesterday Low: $1.42
- Yesterday Volume: 2.24M
- Last Min Volume: 0
- Last Min High: $1.318
- Last Min Low: $1.307
- Last Min VWAP: $0
Company Profile
- Name: PMV Pharmaceuticals, Inc
- Website: https://www.pmvpharma.com
- Listed Date: 2020-09-25
- Location: PRINCETON, NJ
- Market Status: Active
- CIK Number: 0001699382
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $74.19M
- Round Lot: 100
- Outstanding Shares: 52.99M
- Asset Type: CS
RECENT FILINGS FOR PMVP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-09 | 10-Q | View |
| 2025-05-09 | 8-K | View |
| 2025-04-25 | ARS | View |
Latest News on PMVP